Biomedical informatics for proteomics

Nature

Volumn 422, Issue 6928, 2003, Pages 233-237

  Boguskl, Mark S ^a   McIntosh, Martin W ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; COMPUTER SOFTWARE; DATA REDUCTION; DATABASE SYSTEMS; GENES; INFORMATION TECHNOLOGY;

BIOMEDICAL INFORMATICS;

PROTEINS;

MEDICINE;

AMINO ACID SEQUENCE; BIOINFORMATICS; BIOMEDICINE; COMPUTER PROGRAM; DATA BASE; GENE EXPRESSION; INFORMATION PROCESSING; MACROMOLECULE; PHENOMENOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEOMICS; REPRODUCIBILITY; REVIEW; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

BIOMEDICAL RESEARCH; COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; HUMANS; PROTEINS; PROTEOMICS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 0037434977     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature01515     Document Type: Review

References (64)

1. Cambridge Healthtech Institute Conference on Human Proteome Project, 2-4 April 2001, McLean, Virgina 〈:http://www.healthtech.com/2001/hpr/index.htm〉 (2001).
2. Krishna, R. G. & Wold, F. Post-translational modification of proteins. Adv. Enzymol. Relat. Areas Mol. Biol. 67, 265-298 (1993).
3. Keegan, L. P., Gallo, A. & O'Connell, M. A. The many roles of an RNA editor. Nature Rev. Genet. 2. 869-878 (2001).
4. Maniatis, T. & Tasic, B. Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418, 236-243 (2002).
5. Dayhoff, M. O. & Eck, R. V. MASSPEC: a computer program for complete sequence analysis of large proteins from mass spectrometry data of a single sample. Comput. Biol. Med. 1, 5-28 (1970).
6. Anderson, N. G., Matheson, A. & Anderson, N. L. Back to the future: the human protein index(HPI) and the agenda for post-proteomic biology. Proteomics 1, 3-12 (2001).
7. Boguski, M. S. Bioinformatics. Curr. Opin. Genet. Dev. 4, 383-388 (1994).
8. Boguski, M. S. The turning point in genome research. Trends Biochem. Sci. 20, 295-296 (1995).
9. Zuckerkandl, E. & Pauling, L. Molecules as documents of evolutionary history. J. Theor. Biol. 8, 357-366 (1965).
10. Dayhoff, M. O. Computer aids to protein sequence determination. J. Theor. Biol. 8, 97-112 (1965).
11. Doolittle, R. F. Some reflections on the early days of sequence searching. J. Mol. Med. 75, 239-241 (1997).
12. Shortliffe, E. et al. (eds.) Medical Informatics: Computer Applications in Health Care and Biomedicine (Springer, New York, 2000).
13. Hieter, P. & Boguski, M. Functional genomics: it's all how you read it. Science 278, 601-602 (1997).
14. Duyk, G. M. Sharper tools and simpler methods. Nature Genet. 32 (Chipping Forecast II Suppl.), 465-468 (2002).
15. Kohane, I. S., Kho, A. T. & Butte, A. J. Microarrays For an Integrative Genomics (Massachusetts Institute of Technology Press, Cambridge, MA, 2003).
16. Potter, J. D. At the interfaces of epidemiology, genetics and genomics. Nature Rev. Genet. 2, 142-147 (2001).
17. McClatchey, K. D. (ed.) Clinical Laboratory Medicine (Lippincott, Philadelphia, 2002).
18. Huang, J. et al. Effects of ischemia on gene expression. J. Surg. Res. 99, 222-227 (2001).
19. Craven, R. A. & Banks, R. E. Laser capture microdissection and proteomics: possibilities and limitation. Proteomics 1, 1200-1204 (2001).
20. Craven, R. A. & Banks, R. E. Use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis. Methods Enzymol. 356, 33-49 (2002).
21. Margolin, J. From comparative and functional genomics to practical decisions in the clinic: a view from the trenches. Genome Res. 11, 923-925 (2001).
22. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 57, 289-300 (1995).
23. Dayhoff, M. O. & Eck, R. V. Atlas of Protein Sequence and Structure (National Biomedical Research Foundation, Silver Spring, MD. 1966).
24. Smith, T. E. The history of the genetic sequence databases. Genomics 6, 701-707 (1990).
25. Bairoch, A. & Boeckmann, B. The SWISS-PROT protein sequence data bank. Nucleic Acids Res. 19(Suppl.), 2247-2249 (1991).
26. Maglott, D. R. et al. NCBI's LocusLink and RefSeq. Nucleic Acids Res 28, 126-128 (2000).
27. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature Genet. 25, 25-29 (2000).
28. Bader, G. D. et al. BIND - The Biomolecular Interaction Network Database. Nucleic Acids Res. 29, 242-245 (2001).
29. Adkins, J. N. et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell. Proteomics 1, 947-955 (2002).
30. Kratz, A. & Lewandrowski, K. B. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values. N. Engl. J. Med. 339, 1063-1072 (1998).
31. Jung, E. et al. Annotation of glycoproteins in the SWISS-PROT database. Proteomics 1, 262-268 (2001).
32. Anderson, N. L. & Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1, 845-867 (2002).
33. Chakravarti, D. N., Chakravarti, B. & Moutsatsos, I. Informatic tools for proteome profiling. Biotechniques 32(Comput. Proteomics Suppl.), S4-S15 (2002).
34. Liebler, D. C. Introduction to Proteomics (Humana, Totowa, NJ, 2002).
35. The Association of Biomolecular Resource Facilities. Delta Mass: A Database of Protein Post Translational Modifications 〈http://www. abrf.org/index.cfm/dm.home〉 (2002).
36. Wilkins, M. R. et al. High-throughput mass spectrometric discovery of protein post-translational modifications. J. Mol. Biol. 289, 645-657 (1999).
37. Creasy, D. M. & Cottrell, J. S. Error tolerant searching of uninterpreted tandem mass spectrometry data. Proteomics 2, 1426-1434 (2002).
38. Choudhary, J. S. et al. Matching peptide msss spectra to EST and genomic DNA databases. Trends Biotechnol. 19(Suppl.), S17-S22 (2001).
39. Choudhary, J. S. et al. Interrogating the human genome using uninterpreted mass spectrometry data. Proteomics 1, 651-667 (2001).
40. Bafna, V. & Edward, N. SCOPE: a probabilistic model for scoring tandem mass spectra against a peptide database. Bioinformatics 17(Suppl.) S13-S21 (2001).
41. Eng, J., McCormack, A. & Yates, J. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5, 976-989 (1994).
42. Fenyo, D. Identifying the proteome: software tools. Curr. Opin. Biotechnol. 11, 391-395 (2000).
43. Field, H. I., Fenyo, D. & Beavis, R. C. RADARS, a bioinformatics solution that automates proteome mass spectral analysis, optimises protein identification, and archives data in a relational database. Proteomics 2, 36-47 (2002).
44. Perkins, D. N. et al. Probability-based protein identification by searching sequence database using mass spectrometry data. Electrophoresis 20, 3551-3567 (1999).
45. Efron, B. & Tibshirani, R. Empirical Bayes methods and false discovery rates for microarrays. Genet. Epidemiol. 23, 70-86 (2002).
46. Pepe, M. S. et al. Selecting differentially expressed genes from microarray experiments. Biometrics (in the press.
47. Keller, A. et al. Empirical statistical model to estimate the accuracy of peptide identification made by MS/MS and database search. Anal Chem. 74, 5383-5392 (2002).
48. Adam, B. L. et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from Benign prostate hyperplasia and healthy men. Cancer Res. 62, 3609-3614 (2002).
49. Petricoin, E. F. III et al. Serum proteomic patterns for detection of prostate cancer. J. Natl. Cancer Inst. 94, 1576-1578 (2002).
50. Petricoin, E. F. et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359, 572-577 (2002).
51. Qu, Y. et al. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin. Chem. 48, 1835-1843 (2002).
52. Pepe, M. S., et al. Phases of biomarker development for early detection of cancer. J. Natl. Cancer Inst. 93, 1054-1061 (2001).
53. Judson, H. The Eighth Day of Creation: Makers of the Revolution in Biology expand. edn (Cold Spring Harbor Laboratory Press, New York. 1996)
54. Hayles, N. How We Became Posthuman: Virtual Bodies in Cybernetics Literature, and Informatics (University of Chicago Press, Chicago, 1999).
55. Bonini, P. et al. Errors in laboratory medicine. Clin. Chem. 48, 691-698 (2002).
56. Narayanan, S. The preanalytic phase. An important component of laboratory medicine. Am. J. Clin. Pathol. 113, 429-452 (2000).
57. Spellman, P. T. et al. Design and implementation of microarray gene expression markup language (MAGE-ML). Genome Biol. 3, 46 (2002).
58. Brazma, A. et al. Minimum information about a microarray experiment (MIAME) - toward standards for microarray data. Nature Genet. 29, 365-371 (2001).
59. Editorial. Coming to terms with microarrays. Nature Genet. 32, 333-334 (2002).
60. Ball, C. et al. Standards for Microarray Data. Science 298, 539 (2002).
61. Orchard, S., Kersey, P., Hermjakob, H. & Apweiler, R. The HUPO proteomics standards initiative meeting: towards common standards for exchanging proteomics data. Comp. Funct. Genom. 4, 16-19 (2003).
62. Bader, G. D. & Hogue, C. W. BIND - a data specification for storing and describing biomolecular interactions, molecular complexes and pathways. Bioinformatics 16, 465-477 (2000).
63. Abiteboul, S., Buneman, P. & Suciu, D. Data on the Web: From Relations to Semistructured Data and XML (Morgan Kaufmann, San Francisco, 2000).
64. Coyle, F. XML, Web Services, and the Data Revolution (Addison-Wesley, Boston, 2002).